To include your compound in the COVID-19 Resource Center, submit it here.

SCIO-469: SCIO began a U.K. double-blind, placebo-controlled Phase Ib trial in 20 healthy volunteers to assess multiple oral doses of SCIO-469 given over two we

Scios Inc. (SCIO), Sunnyvale, Calif.
Product: SCIO-469

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE